Kyle N. Campbell, PharmD, MS
Vice President, Pharmacy & Quality Measurement
Dr. Campbell is Vice President for Pharmacy and Quality Measurement at HSAG, where he oversees national projects related to quality measure development, healthcare policy and evaluation, and medication safety. His experience includes developing and maintaining diverse types of National Quality Forum-endorsed measures that are used in national reporting programs, evaluating and assessing the impact of quality measures on the healthcare system, advising on national policy related to measure development, designing and implementing quality improvement interventions, and overseeing research studies related to medication safety. He served as a subject matter expert on the development of the 2015 National Impact Assessment of the Centers for Medicare & Medicaid Services (CMS) Quality Measures Report (2015 Impact Report), directed the development of the 2018 Impact Report, and serves as director for the 2021 Impact Report. In this role, he also oversaw the development of the CMS Quality Measure Development Plan (MDP) and accompanying MDP Annual Reports. He has been invited to speak at numerous national conferences related to quality measure development and has served on national expert panels related to both measure development and medication safety. Dr. Campbell earned his pharmacy degree from the University of Florida and his Master’s degree from the University of South Florida.
Under Dr. Campbell’s supervision, the following team leads manage staff activities for contracts with CMS and other clients:
Melissa Castora-Binkley, PhD, MA, PMP
Dr. Castora-Binkley leads a multidisciplinary team investigating the impact of quality measures in CMS reporting programs and developing the triennial Impact Assessment Report. She is the team’s key liaison with CMS and directs project management and analytic activities, including acquisition of large, complex datasets; analytic methodology; data analysis; and reporting. Previously Dr. Castora-Binkley assisted in managing a project team that developed, maintained, and implemented quality measures for the CMS Inpatient Psychiatric Facility Quality Reporting Program. She also led an HSAG team collaborating with IMPAQ International, LLC, on the Development and Implementation of Quality Rating System Measures for Qualified Health Plans. HSAG led the information-gathering and measure development aspects of the CMS project, including measure specifications and convening of a technical expert panel. Dr. Castora-Binkley also assisted with research activities for the End Stage Renal Disease Network National Coordinating Council. She is a certified Project Management Professional and has a PhD in Aging Studies from the University of South Florida with a concentration in Health Services Research and a Master of Arts degree in Applied Sociology from the University of Central Florida with concentrations in Gerontology and Social Policy. She has taught at the university level, held editorial responsibilities for peer review outlets, and authored and presented journal articles at professional conferences.
Kendra Hanley, MS, BA
Director, Clinical Quality Measures
Ms. Hanley is a nationally recognized expert with 15 years of experience in the development and specification of clinical quality measures, with an emphasis on electronic clinical quality measures, or eCQMs. Currently as Director for Clinical Quality Measures for HSAG, she leads a team responsible for the CMS Quality Measure Development Plan (MDP) project, which is mandated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). She also has served as an eCQM subject matter expert for the Hospital Inpatient Value, Incentives, and Quality Reporting (VIQR) Outreach and Education Support Contract. Ms. Hanley has served on national committees examining methodological issues related to eCQMs. She participates in many of the national consensus-based initiatives to maintain and evolve the technology standards used in eCQMs and has a thorough understanding of quality improvement and measure specification methodologies. Prior to joining HSAG, Ms. Hanley was Director, Measure Specification Operations, for the PCPI® (formerly the AMA-convened Physician Consortium for Performance Improvement), where she managed the team responsible for all aspects of specification development and maintenance for quality measures developed by the PCPI, including their use in federal quality reporting programs such as the Physician Quality Reporting System and the CMS Electronic Health Record Incentive Program for Eligible Professionals. Previously Ms. Hanley managed the submission of inpatient quality measure data for three acute care facilities in the Chicago area. Ms. Hanley has a Master of Science Degree in Health Systems Management from Rush University in Chicago, IL.
Carolyn M. Lockwood, MSN, RN
Director, Clinical Quality Measures
Ms. Lockwood is a Director of Clinical Quality Measures on the Impact Assessment of CMS Quality and Efficiency Measures contract, for which HSAG produces the CMS Measure Development Plan Annual Report. She leads a team developing the Quality Measure Index, a quantitative tool to assess quality measures. She also conducts environmental scans and contributes clinical insight related to healthcare providers. Previously she served on a team that developed quality measures for the Quality Payment Program. Ms. Lockwood oversaw submission of measures to the National Quality Forum and reviewed research for annual measure updates. She also has conducted workflow assessments within physician practices to determine the feasibility of proposed measures, collaborated with healthcare facilities to optimize use of electronic health records, submitted quality measure data and reviewed related reports, and designed internal quality measures to capture data metrics for improving patient safety and outcomes. Licensed in Pennsylvania as a Registered Nurse, she has a Master of Science degree in Nursing Informatics and a Bachelor of Science degree in Nursing. Prior to her clinical informatics work, she had more than 25 years of experience in clinical nursing and staff development.
Megan Keenan, MPH
Ms. Keenan has six years of experience managing complex projects that incorporate measure development, public reporting of quality data, stakeholder engagement, and evaluating the impact of socioeconomic status on patient outcomes. She has managed the development of four de novo clinical quality measures and supported the successful maintenance and implementation of approximately 20 clinical quality measures across various CMS programs. At HSAG, she directed a project team that developed, maintained, and implemented quality measures for the CMS Inpatient Psychiatric Facility Quality Reporting Program. Previously, Ms. Keenan provided similar expertise for the development and maintenance of quality measures for acute care facilities as a Project Manager at the Yale Center for Outcomes Research and Evaluation (CORE). While at The Commonwealth Fund earlier in her career, Ms. Keenan conducted outreach to members of the U.S. Congress on health services research that had implications for public policy. She holds a Bachelor of Science degree in Biochemistry from Northeastern University and a Master’s degree in Health Policy and Administration from the Yale School of Public Health.
Allison Peel, DC, MHA, MPH, PMP
Director, Clinical Quality Measures
Dr. Peel brings 15 years of clinical and 12 years of measure development and maintenance experience to her role at HSAG. She currently serves as the primary point of contact on the MACRA Cooperative Agreement Technical Assistance (CATA) task order, successfully launching CMS’s initial support project for recipient measure developers. In this role, she directs a team of measure experts who identify and tailor support for recipients as they develop a variety of measures, including patient-reported outcome performance measures and electronic clinical quality measures. Previously Dr. Peel directed the measure implementation help desk team for the CMS Physician Quality Reporting System (PQRS) and Electronic Prescribing program. She has extensive experience with development of educational products related to quality measures, including presentations, frequently asked questions, fact sheets, and guidance documents. She regularly reviews recipient progress reports and measure development products, providing recommendations regarding best practices for both measure development and project success. She has led clinical analytics teams supporting CMS on physician quality measures since the inception of the national physician-based quality measures program in 2007. She led the teams that maintained over 300 measure specifications for the national program, creating multiple versions of measure specifications, implementation, and other educational materials specific to understanding the measures, the program, and multiple data submission methods. Dr. Peel has participated on expert panels with CMS and the National Quality Forum (NQF) to improve measure development. Her experience includes supporting information-gathering activities; providing clinical subject matter expertise through implementation of quality measures; facilitation of collaborative ad hoc analyses; and drafting responses to support CMS in rulemaking specific to quality measures and program rules. Her 15 years of clinical experience began as an owner and chiropractic physician. She developed quality assurance/control programs for clinicians in radiology and radiation safety and oversaw operations for internal medicine, physical therapy, mental health, and chiropractic services. Dr. Peel received a Doctor of Chiropractic degree from Palmer College of Chiropractic, where she also completed a radiology residence. She holds Master’s degrees in Public Health and Healthcare Administration from Des Moines (Iowa) University and is certified as a Project Management Professional and as an Administrator in Physician Practice Management.
Tsu-Hsuan “Sherry” Yang, PharmD
Clinical Pharmacist Researcher and Program Manager
Dr. Yang provides project management and clinical expertise to HSAG on CMS contracts and serves as an investigator for research projects focusing on medication safety. Currently she is leading a 26-month study to develop a risk-prediction model using administrative claims data to assess bleeding risk for patients taking anticoagulants. This research is funded by the Gordon and Betty Moore Foundation. Dr. Yang was the principal investigator for two research projects for the Centers for Disease Control and Prevention, each aimed at developing and validating diagnosis code algorithms for potential use in adverse drug event surveillance and quality improvement initiatives. The first study produced an ICD-10 diagnosis code algorithm for identifying bleeding events associated with outpatient anticoagulant exposure; the second study validated diagnosis codes for identifying hypoglycemic events associated with the use of diabetes agents. As a program manager, she also assists in evaluating research funding opportunities, preparing research proposals, and resource planning. Dr. Yang previously oversaw daily operations of CMS measure development and maintenance projects. As Project Director, she oversaw data analysis, subcontractor activities, technical expert panel deliberations, and measure development and maintenance. She was involved in the maintenance of clinical algorithms and technical specifications for measures. She is a Registered Pharmacist in Florida and North Carolina. She graduated from the University of North Carolina PharmD program and holds a Bachelor of Science degree in Biochemistry from North Carolina State University. She completed a two-year fellowship at the University of Florida College of Pharmacy, focusing on medication therapy management program evaluation and outcome research.